NIDHI PATEL: Open Payments
NPI 1003417692 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,210 in 61 payments from 15 companies in 2025. Trend: 2023 $753 · 2024 $1,386 · 2025 $1,210
Food & beverage: $1,210
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $234 |
| Otsuka America Pharmaceutical, Inc. | 8 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $167 |
| E.R. Squibb & Sons, L.L.C. | 5 | $118 |
| Lundbeck LLC | 6 | $117 |
| Neurocrine BioSciences, Inc. | 3 | $76 |
| Vanda Pharmaceuticals Inc. | 3 | $58 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
| Alkermes, Inc. | 2 | $37 |
| Almatica Pharma LLC | 2 | $36 |
Products named: REXULTI, VRAYLAR, CAPLYTA, COBENFY, INGREZZA, ABILIFY ASIMTUFII, SPRAVATO, LOREEV XR.
Industry payments across TX — which companies pay providers there.
